Indian government has provided Rs 37,000 crore fertiliser subsidy till July 22, 2024-25 fiscal, ensuring affordable crop nutrients for farmers. Learn about the subsidy details and fertiliser...

Bharti Airtel denies data breach claims, stating they are a desperate attempt to damage the brand's reputation. The company conducted a thorough investigation and found no evidence of a breach.

Study highlights streamlining FDI, boosting R&D and manufacturing as key factors for India to achieve its USD 5 billion defence export target by 2024-25.

A new survey reveals how AI integration in drone technology is boosting capabilities, efficiency, and operational intelligence in India

A report suggests India's drone industry needs a wider PLI scheme and ecosystem development to achieve its goal of becoming a global drone hub by 2030. Read about the key drivers and challenges.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.